Sexual Orientation and Gynecomastia After Bilateral Orchiectomy
Sexual orientation does not change after bilateral orchiectomy, but gynecomastia is a recognized side effect of the resulting hypotestosteronemia, though it occurs less frequently with orchiectomy compared to other forms of androgen deprivation therapy.
Sexual Orientation (Sexual Preference)
There is no evidence that bilateral orchiectomy causes changes in sexual orientation or sexual preference. The procedure affects sexual function and libido through testosterone depletion, but does not alter the fundamental direction of sexual attraction. The available evidence addresses:
- Loss of libido (decreased sexual desire)
- Erectile dysfunction
- Changes in sexual interest, activity, and pleasure
- Body image concerns
These are functional and psychological impacts on sexuality, not changes in sexual orientation 1.
Recent research confirms that orchiectomy significantly impacts sexual function, with patients showing poorer genital self-image, increased erectile dysfunction, and greater sexual dissatisfaction 2. However, these represent changes in sexual capacity and psychological well-being, not sexual preference.
Gynecomastia Risk
Gynecomastia is a documented side effect of bilateral orchiectomy, occurring due to the hypotestosteronemia (low testosterone) that results from the procedure 1.
Comparative Risk Profile
According to ASCO guidelines, among androgen deprivation approaches for prostate cancer:
- Bilateral orchiectomy has the LOWEST incidence of gynecomastia compared to other hormonal therapies
- Nonsteroidal antiandrogen therapy has higher rates
- Diethylstilbestrol and estrogen therapy have the highest rates 3
Clinical Context
While gynecomastia can occur with orchiectomy, research indicates that approximately 50% or more of patients receiving hormone therapy for prostate cancer experience gynecomastia through multiple mechanisms 3. The severity is typically mild to moderate, though it can be treatment-limiting in some cases.
Management Considerations
If gynecomastia develops or is a concern:
- Prophylactic radiotherapy can decrease hormone-induced gynecomastia incidence by more than 50% 3
- Prophylactic tamoxifen is an alternative that may be more convenient 3
- Tamoxifen can also mitigate or resolve gynecomastia during its early proliferative phase 3
- Surgery is warranted for severe, long-standing gynecomastia when medical therapies are less likely to succeed 3
Important Caveat
The emotional and psychological impact of orchiectomy itself is often a greater concern to patients than the physical surgical risks. When given the choice between surgical and medical castration, most patients initially select medical approaches, reflecting the psychological significance of the procedure 1.